Mainz Biomed Provides Year-End Corporate Review 2023
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous09.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides Year-End Corporate Review 2023 European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Co...
Source: pharmiweb.com